MJA 2009; 191 (11/12): 625-629
Authors: Danika V Hall, Sandra C Jones and Donald C Iverson
“Conclusion: The educational value of industry-sponsored DAA [disease awareness advertising] could be improved if regulations and guidelines stipulated disease information requirements, such as inclusion of risk-factor and symptom information. Regulators should provide guidelines for “unbranded product advertisements” and the acceptability of other persuasive techniques. Further research into DAA is required and should consider advertisements in a range of media, and behavioural responses.”
Find article here.